Heart Disease Trial, Recruiting NCT06634121 Sponsor: LMU Klinikum Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06634121
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have given written consent to participate
  • People whose Heart Team (a group of heart specialists) has recommended a procedure called M-TEER (a minimally invasive treatment for a heart valve problem)

Who may not be able to join:

  • People who have mitral stenosis, meaning their mitral heart valve is narrowed beyond a certain level (confirm with trial site)
  • People who are in cardiogenic shock or whose heart and blood pressure are not stable at the time of the procedure
  • People who have an active heart valve infection (endocarditis)
  • People who are already taking part in another interventional cardiology study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jörg Hausleiter, Prof. Dr., LMU Klinikum

Phone: +4989440072361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
LMU Klinikum
Registry
ClinicalTrials.gov
Start date
1 April 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Postprocedural residual MR measured by 3D EROA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov